Clinical Trial Update: Multicenter Study Evaluating the Safety of Proellex® in Premenopausal Women With Uterine Fibroids [Phase 3]

View source ↗

Summary

A Phase 3 multicenter trial assessing the safety of Proellex (telapristone acetate) in premenopausal women with uterine fibroids was terminated, with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Drugs mentioned

• Proellex (telapristone acetate)

Snippet

Sponsor: Repros Therapeutics Inc. | Conditions: Uterine Fibroids | Phase 3 | Status: TERMINATED | Results posted: 2014-08-21